Halbert Hargrove Global Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-42
Closed -$2.62K 638
2025
Q3
$2.62K Buy
+42
New +$2.92K ﹤0.01% 515

Other funds holding PBH

Halbert Hargrove Global Advisors's PBH Position: Q4 2025 in Review

Halbert Hargrove Global Advisors sold out of Prestige Consumer Healthcare (PBH) in Q4 2025, closing a stake of 42 shares — an estimated $2.62K sold.

Halbert Hargrove Global Advisors first reported a position in PBH in Q3 2025 and held it in 1 quarter. The position peaked at $2.62K in Q3 2025. 354 funds tracked by Wall St. Rank hold PBH as of Q4 2025.

  • Halbert Hargrove Global Advisors reported no remaining Prestige Consumer Healthcare position as of Q4 2025 after selling out during the quarter.
  • Halbert Hargrove Global Advisors sold 42 Prestige Consumer Healthcare shares in Q4 2025, an estimated $2.62K.
  • Halbert Hargrove Global Advisors first reported a position in Prestige Consumer Healthcare in Q3 2025 and held it in 1 quarter.
  • Halbert Hargrove Global Advisors's Prestige Consumer Healthcare position peaked at $2.62K in Q3 2025.
  • 354 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2025.

Based on Halbert Hargrove Global Advisors's 13F filing for Q4 2025, filed 23 Jan 2026.